Uromitexan 100mg/ml Solution for Injection or infusion (4ml ampoule) Malta - English - Medicines Authority

uromitexan 100mg/ml solution for injection or infusion (4ml ampoule)

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - mesna - solution for infusion or injection - mesna 100 mg/ml - all other therapeutic products

Uromitexan 100mg/ml Solution for Injection or infusion (10ml ampoule) Malta - English - Medicines Authority

uromitexan 100mg/ml solution for injection or infusion (10ml ampoule)

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - mesna - solution for infusion or injection - mesna 100 mg/ml - all other therapeutic products

Hydromorphone hydrochloride 20 mg/ml solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

hydromorphone hydrochloride 20 mg/ml solution for injection/infusion

as kalceks - hydromorphone hydrochloride - solution for injection/infusion - hydromorphone

Hydromorphone hydrochloride 50 mg/ml solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

hydromorphone hydrochloride 50 mg/ml solution for injection/infusion

as kalceks - hydromorphone hydrochloride - solution for injection/infusion - hydromorphone

Myozyme 50mg powder for concentrate for solution for infusion vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

myozyme 50mg powder for concentrate for solution for infusion vials

genzyme therapeutics ltd - alglucosidase alfa - powder for solution for infusion - 50mg

MYOZYME alglucosidase alfa-rch 50 mg / 10 mL powder for concentrate for solution for infusion Australia - English - Department of Health (Therapeutic Goods Administration)

myozyme alglucosidase alfa-rch 50 mg / 10 ml powder for concentrate for solution for infusion

sanofi-aventis australia pty ltd - alglucosidase alfa, quantity: 52.5 mg - injection, powder for - excipient ingredients: monobasic sodium phosphate monohydrate; polysorbate 80; mannitol; nitrogen - myozyme (alglucosidase alfa-rch) is indicated for the long-term treatment of patients with a confirmed diagnosis of pompe disease (acid alfa-glucosidase deficiency).

Uromitexan 100mg/ml Solution for Injection or Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

uromitexan 100mg/ml solution for injection or infusion

baxter holding b.v. - mesna - solution for injection/infusion - 100 milligram(s)/millilitre - detoxifying agents for antineoplastic treatment; mesna

Hydromorphone Hydrochloride 20 mg/ml Solution for Injection / Concentrate for Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

hydromorphone hydrochloride 20 mg/ml solution for injection / concentrate for solution for infusion

ethypharm - hydromorphone hydrochloride - solution for injection/infusion - 20 milligram(s)/millilitre - natural opium alkaloids; hydromorphone

Hydromorphone Hydrochloride 50 mg/ml Solution for Injection / Concentrate for Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

hydromorphone hydrochloride 50 mg/ml solution for injection / concentrate for solution for infusion

ethypharm - hydromorphone hydrochloride - solution for injection/infusion - 50 milligram(s)/millilitre - natural opium alkaloids; hydromorphone

Labetalol 5 mg/ml solution for injection/ infusion Malta - English - Medicines Authority

labetalol 5 mg/ml solution for injection/ infusion

s.a.l.f s.p.a laboratorio farmacologico via marconi, 2, 24069, cenate sotto bergamo, italy - labetalol hydrochloride - solution for injection/infusion - labetalol hydrochloride 5 mg/ml - beta blocking agents